3Lockshin B, Harrison R, McLean R, et al. Outcomes in ixekizumab patients following exposure to secukinumab and other biologics in the Corrona Psoriasis Registry. Poster presented at: Innovations in Dermatology Virtual Spring Conference; March 16-20, 2021.
4Corrona announces name change to CorEvitas and expanded strategic direction. Press release. CorEvitas, LLC; March 9, 2021. Accessed April 8, 2021. https://www.corevitas.com/node/425